Corporate News 24-May-17
Orchid Pharma receives ANDA approval for Aripiprazole Tablets
From USFDA
Orchid Pharma has received ANDA approval from USFDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg.
Previous News
Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
( Hot Pursuit - 29-Jun-24 10:08 )
Orchid Pharma to announce Quarterly Result
( Corporate News - 30-Oct-23 19:26 )
Orchid Pharma to convene board meeting
( Corporate News - 07-Feb-22 10:23 )
Orchid Pharma reports consolidated net profit of Rs 7.59 crore in the December 2022 quarter
( Results - Announcements 10-Feb-23 07:38 )
Orchid Pharma to discuss results
( Corporate News - 10-Aug-21 11:07 )
Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
( Corporate News - 28-Jun-24 19:23 )
Orchid Pharma announces board meeting date
( Corporate News - 07-Aug-19 13:44 )
Orchid Pharma drops after bulk deal
( Hot Pursuit - 20-Dec-17 09:33 )
Orchid Pharma reports consolidated net loss of Rs 44.72 crore in the December 2020 quarter
( Results - Announcements 10-Feb-21 08:08 )
Orchid Chemicals & Pharmaceuticals secures USFDA approval for ANDA
( Corporate News - 12-Jun-15 18:54 )
Orchid Chemicals & Pharmaceuticals reports net loss of Rs 50.80 crore in the June 2012 quarter
( Results - Announcements 14-Aug-12 20:37 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
